MU
32
-6
PG
50
2
LB
63
-4
CMS
58
-2
DFS
67
-3
EQT
57
-3
LNC
45
-4
DIS
62
2
REGN
42
-2
HCP
70
-4
T
48
3
TXT
62
2
UHS
54
-4
AVY
53
2
AES
41
2
WHR
70
4
SCHW
65
-2
DE
36
-2
MS
80
-3
MPC
47
3
MU
32
-6
PG
50
2
LB
63
-4
CMS
58
-2
DFS
67
-3
EQT
57
-3
LNC
45
-4
DIS
62
2
REGN
42
-2
HCP
70
-4
T
48
3
TXT
62
2
UHS
54
-4
AVY
53
2
AES
41
2
WHR
70
4
SCHW
65
-2
DE
36
-2
MS
80
-3
MPC
47
3
Financhill
Back

Arcturus Therapeutics Holdings Vs. Neurogene Industry Stock Comparison

Sell
32

ARCT
Arcturus Therapeutics Holdings

Last Price:
19.11
Seasonality Move:
4.49%
Sell
5

NGNE
Neurogene

Last Price:
39.99
Seasonality Move:
50.43%
Sell
32
Arcturus Therapeutics Holdings (ARCT) is a Sell

Is Arcturus Therapeutics Holdings a Buy, Sell or Hold?

  • The current Arcturus Therapeutics Holdings [ARCT] share price is $19.18. The Score for ARCT is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • ARCT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
5
Neurogene (NGNE) is a Sell

Is Neurogene a Buy, Sell or Hold?

  • The current Neurogene [NGNE] share price is $39.54. The Score for NGNE is 5, which is 90% below its historic median score of 50, and infers higher risk than normal.
  • NGNE is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

ARCT Stock Price Chart

What is Arcturus Therapeutics Holdings's stock price today?

  • The Arcturus Therapeutics Holdings share price today is $19.18
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ARCT is experiencing selling pressure, which indicates risk of future bearish movement.

NGNE Stock Price Chart

What is Neurogene's stock price today?

  • The Neurogene share price today is $39.54
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NGNE is experiencing selling pressure, which indicates risk of future bearish movement.

ARCT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.49 Sell
Relative Strength Index (14 RSI): 46.04 Sell
Chaikin Money Flow: -240644 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (18.46 - 20.82) Sell
Bollinger Bands (100): (19.25 - 23.41) Sell

NGNE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.3 Buy
Relative Strength Index (14 RSI): 39.1 Sell
Chaikin Money Flow: -346626 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (43.29 - 61.53) Sell
Bollinger Bands (100): (34.11 - 50.51) Sell

ARCT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 18.99 Buy
20-day SMA: 19.26 Sell
50-day SMA: 20.58 Sell
200-day SMA: 27.29 Sell
8-day EMA: 19.22 Sell
20-day EMA: 19.5 Sell
50-day EMA: 20.49 Sell
200-day EMA: 24.49 Sell

NGNE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 60.39 Sell
20-day SMA: 53.17 Sell
50-day SMA: 46.66 Sell
200-day SMA: 38.93 Buy
8-day EMA: 54.03 Sell
20-day EMA: 53.18 Sell
50-day EMA: 48.36 Sell
200-day EMA: 38.47 Buy

Arcturus Therapeutics Holdings Earnings Growth & ARCT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.85 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.30 per share, and an increase next year of $0.97 per share.

Neurogene Earnings Growth & NGNE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.90 per share.

Arcturus Therapeutics Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Neurogene Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):